Overview
Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery
Status:
Recruiting
Recruiting
Trial end date:
2024-12-01
2024-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of Novi SadTreatments:
Dexmedetomidine
Propofol
Criteria
Inclusion Criteria:- patients undergoing open heart surgery with the use of cardiopulmonary bypass
(including coronary artery bypass grafting, valve repair/replacement, and combined)
- left ventricular ejection fraction (LVEF) >40%.
Exclusion Criteria:
- preoperative atrial fibrillation
- previous history of interventionally treated arrhythmias
- second and third degree atrioventricular block
- bradycardia with heart rate ≤50/min
- pacemaker
- renal or hepatic insufficiency
- emergency procedures
- history of serious mental illness, delirium, and severe dementia